https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-28 / Expert Opin Biol Ther 2011 Apr;11(4):441-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-28 / Expert Opin Biol Ther 2011 Apr;11(4):441-52011-01-28 00:00:002019-02-15 08:52:18Dendritic cell vaccination against ovarian cancer–tipping the Treg/TH17 balance to therapeutic advantage?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-18 / Mol. Ther. 2011 Apr;19(4):797-804
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-18 / Mol. Ther. 2011 Apr;19(4):797-8042011-01-18 00:00:002011-01-18 00:00:00Oncolytic virus-initiated protective immunity against prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-18 / Am. J. Reprod. Immunol. 2011 Jun;65(6):597-609
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-18 / Am. J. Reprod. Immunol. 2011 Jun;65(6):597-6092011-01-18 00:00:002019-02-15 08:40:09Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-04 / Int J Hyperthermia 2011;27(1):63-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-04 / Int J Hyperthermia 2011;27(1):63-732011-01-04 00:00:002019-02-15 10:00:33KNK437, a benzylidene lactam compound, sensitises prostate cancer cells to the apoptotic effect of hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / J. Immunother. 2011 Jan;34(1):100-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / J. Immunother. 2011 Jan;34(1):100-62011-01-01 00:00:002019-02-15 08:50:46Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Drugs 2011 Jan;71(1):101-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Drugs 2011 Jan;71(1):101-82011-01-01 00:00:002019-02-15 08:52:53Sipuleucel-T: in metastatic castration-resistant prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Int J Hyperthermia 2011;27(3):275-85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Int J Hyperthermia 2011;27(3):275-852011-01-01 00:00:002019-02-15 09:17:21Inhibition of B16 murine melanoma metastasis and enhancement of immunity by fever-range whole body hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Curr. Pharm. Des. 2011;17(23):2439-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Curr. Pharm. Des. 2011;17(23):2439-672011-01-01 00:00:002019-02-15 08:46:39New perspectives in glioma immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Zhonghua Fu Chan Ke Za Zhi 2011 Jan;46(1):52-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Zhonghua Fu Chan Ke Za Zhi 2011 Jan;46(1):52-72011-01-01 00:00:002019-02-15 08:45:50[Study on the specific immunity induced by dendritic cell vaccine loading allogenic microvascular endothelial cell bEnd.3 antigen against U14 cervical cancer cell in mice]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Therapy 2011 Jan;8(1):43-54
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Therapy 2011 Jan;8(1):43-542011-01-01 00:00:002019-02-15 08:35:15Immunotherapy as a strategy for the treatment of non-small-cell lung cancer
